BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND KLF4, EZF, 9314, ENSG00000136826, GKLF, O43474 AND Treatment
27 results:

  • 1. Paternity through use of assisted reproduction technology in male adult and childhood cancer survivors: a nationwide register study.
    Kitlinski M; Giwercman A; Elenkov A
    Hum Reprod; 2023 May; 38(5):973-981. PubMed ID: 36773319
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Anti-ovarian cancer actions and pharmacological targets of plumbagin.
    Liang K; Pan X; Chen Y; Huang S
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Jun; 396(6):1205-1210. PubMed ID: 36692828
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Stemness potency and structural characteristics of thyroid cancer cell lines.
    Ozisik H; Ozdil B; Sipahi M; Erdogan M; Cetinkalp S; Ozgen G; Saygili F; Oktay G; Aktug H
    Pathol Res Pract; 2023 Jan; 241():154262. PubMed ID: 36527836
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Ethanol exposure of human pancreatic normal ductal epithelial cells induces EMT phenotype and enhances pancreatic cancer development in KC (Pdx1-Cre and LSL-Kras
    Yu W; Ma Y; Roy SK; Srivastava R; Shankar S; Srivastava RK
    J Cell Mol Med; 2022 Jan; 26(2):399-409. PubMed ID: 34859959
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression.
    Li W; Wu L; Jia H; Lin Z; Zhong R; Li Y; Jiang C; Liu S; Zhou X; Zhang E
    Cell Mol Biol Lett; 2021 Nov; 26(1):45. PubMed ID: 34758724
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas.
    Luan Z; Morimoto Y; Fushimi A; Yamashita N; Suo W; Bhattacharya A; Hagiwara M; Jin C; Kufe D
    Carcinogenesis; 2022 Feb; 43(1):67-76. PubMed ID: 34657147
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Development and in vitro characterisation of an induced pluripotent stem cell model of ovarian cancer.
    Bindhya S; Sidhanth C; Krishnapriya S; Garg M; Ganesan TS
    Int J Biochem Cell Biol; 2021 Sep; 138():106051. PubMed ID: 34343671
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/klf4 axis.
    Wang K; Wang Y; Wang Y; Liu S; Wang C; Zhang S; Zhang T; Yang X
    Stem Cell Res Ther; 2021 Mar; 12(1):186. PubMed ID: 33726845
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. LRH-1 (liver receptor homolog-1) derived affinity peptide ligand to inhibit interactions between β-catenin and LRH-1 in pancreatic cancer cells: from computational design to experimental validation.
    Pouraghajan K; Mahdiuni H; Ghobadi S; Khodarahmi R
    J Biomol Struct Dyn; 2022 Apr; 40(7):3082-3097. PubMed ID: 33183172
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Combined Poziotinib with Manidipine treatment Suppresses Ovarian cancer Stem-Cell Proliferation and Stemness.
    Lee H; Kim JW; Lee DS; Min SH
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036254
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A narrative review of targeted therapy in meningioma, pituitary adenoma, and craniopharyngioma of the skull base.
    Martinez NL; Khanna O; Farrell CJ
    Chin Clin Oncol; 2020 Dec; 9(6):75. PubMed ID: 32819111
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma.
    Zhang K; Wang W; Chen L; Liu Y; Hu J; Guo F; Tian W; Wang Y; Xue F
    Oncol Rep; 2020 Sep; 44(3):909-926. PubMed ID: 32705213
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. High Phosphoglycerate Dehydrogenase Expression Induces Stemness and Aggressiveness in Thyroid cancer.
    Jeon MJ; You MH; Han JM; Sim S; Yoo HJ; Lee WK; Kim TY; Song DE; Shong YK; Kim WG; Kim WB
    Thyroid; 2020 Nov; 30(11):1625-1638. PubMed ID: 32438862
    [No Abstract]    [Full Text] [Related]  

  • 14. The Effect of 3'-Hydroxy-3,4,5,4'-Tetramethoxy -stilbene, the Metabolite of the Resveratrol Analogue DMU-212, on the Motility and Proliferation of Ovarian cancer Cells.
    Nowicki A; Skupin-Mrugalska P; Jozkowiak M; Wierzchowski M; Rucinski M; Ramlau P; Krajka-Kuzniak V; Jodynis-Liebert J; Piotrowska-Kempisty H
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046103
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
    Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
    J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Celastrol strongly inhibits proliferation, migration and cancer stem cell properties through suppression of Pin1 in ovarian cancer cells.
    Li X; Wang H; Ding J; Nie S; Wang L; Zhang L; Ren S
    Eur J Pharmacol; 2019 Jan; 842():146-156. PubMed ID: 30389635
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid cancer.
    Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
    Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic cancer Cells through Silencing of Krüppel-Like Factor 4 Expression.
    Xie VK; Li Z; Yan Y; Jia Z; Zuo X; Ju Z; Wang J; Du J; Xie D; Xie K; Wei D
    Clin Cancer Res; 2017 Sep; 23(18):5585-5597. PubMed ID: 28659310
    [No Abstract]    [Full Text] [Related]  

  • 19. DNA methylation and Transcriptome Changes Associated with Cisplatin Resistance in Ovarian cancer.
    Lund RJ; Huhtinen K; Salmi J; Rantala J; Nguyen EV; Moulder R; Goodlett DR; Lahesmaa R; Carpén O
    Sci Rep; 2017 May; 7(1):1469. PubMed ID: 28473707
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. klf4 expression enhances the efficacy of chemotherapy drugs in ovarian cancer cells.
    Wang B; Shen A; Ouyang X; Zhao G; Du Z; Huo W; Zhang T; Wang Y; Yang C; Dong P; Watari H; Pfeffer LM; Yue J
    Biochem Biophys Res Commun; 2017 Mar; 484(3):486-492. PubMed ID: 28108288
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.